Skip to main content
Figure 2 | Cardiovascular Diabetology

Figure 2

From: Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease

Figure 2

Relation between metabolic parameters of adipose tissue (dys) function and EV-markers in patients with manifest cardiovascular disease. Ī² with 95% CI indicates the difference in log EV-cystatin C, log EV-serpin G1, square root EV-serpin F2 or log EV-CD14 levels per unit increase in log hsCRP, log adiponectin, log HOMA-IR or HDL-cholesterol, adjusted for age, sex, current smoking, eGFR, type 2 diabetes, blood pressure lowering medication, lipid lowering medication, platelet aggregation inhibitors and year of inclusion in SMART. AdipoQ: adiponectin.

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840